Drug Metabolite
Drug metabolite results when a drug is metabolized into a modified form which continues to produce effects. Drug metabolism redox reactions such as heteroatom dealkylations, hydroxylations, heteroatom oxygenations, reductions, and dehydrogenations can yield active metabolites, and in rare cases even conjugation reactions can yield an active metabolite.
Products Related to Drug Metabolite(546)
- GC49157rac-5-carboxy TolterodineCAS: 1076199-77-3Purity: >98.00%
An inactive metabolite of tolterodine
- GC491592-(1-Piperazinyl)pyrimidineCAS: 20980-22-7Purity: >98.00%
An α 2 -AR antagonist and active metabolite of azapirones
- GC49189(E/Z)-4-hydroxy Tamoxifen-d5CAS: 2470232-57-4Purity: >99.00%
An internal standard for the quantification of (E/Z)-4-hydroxy tamoxifen
- GC49202Desmethyl Mirtazapine (hydrochloride)CAS: 1188265-41-9Purity: >98.00%
A metabolite of mirtazapine
- GC49203rac-Desethyl Oxybutynin (hydrochloride)CAS: 81039-77-2Purity: >95.00%
An active metabolite of oxybutynin
- GC49210N-desethyl Brinzolamide (oxalate)CAS: 2775292-24-3Purity: >95.00%
An active metabolite of brinzolamide
- GC49211O-desmethyl Brinzolamide (hydrochloride)CAS: 2967475-56-3Purity: >98.00%
An active metabolite of brinzolamide
- GC49217Trifluoperazine N-GlucuronideCAS: 165602-90-4Purity: >70.00%
يتم التعبير عن Trifluoperazine N-Glucuronide (UGT1A4) ، كأحد الأشكال الإسوية UGT1A البشرية ، في الكبد
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC49130 | Hydroxy Celecoxib | 170571-00-3 | >95.00% | |
An inactive metabolite of celecoxib | ||||
| GC49131 | Dehydro Warfarin | 67588-18-5 | >95.00% | |
A metabolite of (±)-warfarin | ||||
| GC49133 | N-hydroxy Riluzole | 179070-90-7 | >95.00% | |
A metabolite of riluzole | ||||
| GC49147 | Carboxyphosphamide | 22788-18-7 | >95.00% | |
An inactive metabolite of cyclophosphamide | ||||
| GC49152 | Celecoxib Carboxylic Acid | 170571-01-4 | >95.00% | |
An inactive metabolite of celecoxib | ||||
| GC49156 | Etodolac Acyl Glucuronide | 79541-43-8 | >90.00% | |
A phase II metabolite of etodolac | ||||
| GC49157 | rac-5-carboxy Tolterodine | 1076199-77-3 | >98.00% | |
An inactive metabolite of tolterodine | ||||
| GC49159 | 2-(1-Piperazinyl)pyrimidine | 20980-22-7 | >98.00% | |
An α 2 -AR antagonist and active metabolite of azapirones | ||||
| GC49173 | N-Despropyl Ropinirole | 106916-16-9 | >98.00% | |
An active metabolite of ropinirole | ||||
| GC49174 | Desmethyl Bosentan | 253688-61-8 | >95.00% | |
An active metabolite of bosentan | ||||
| GC49179 | (S)-O-Desmethyl Naproxen | 52079-10-4 | >98.00% | |
A metabolite of (S)-naproxen | ||||
| GC49184 | Palonosetron N-oxide | 813425-83-1 | >95.00% | |
A metabolite of palonosetron | ||||
| GC49185 | Mirtazapine N-oxide | 155172-12-6 | >95.00% | |
A metabolite of mirtazapine | ||||
| GC49186 | O-Demethyl Apremilast | 1384441-38-6 | >95.00% | |
An active metabolite of apremilast | ||||
| GC49189 | (E/Z)-4-hydroxy Tamoxifen-d5 | 2470232-57-4 | >99.00% | |
An internal standard for the quantification of (E/Z)-4-hydroxy tamoxifen | ||||
| GC49202 | Desmethyl Mirtazapine (hydrochloride) | 1188265-41-9 | >98.00% | |
A metabolite of mirtazapine | ||||
| GC49203 | rac-Desethyl Oxybutynin (hydrochloride) | 81039-77-2 | >95.00% | |
An active metabolite of oxybutynin | ||||
| GC49210 | N-desethyl Brinzolamide (oxalate) | 2775292-24-3 | >95.00% | |
An active metabolite of brinzolamide | ||||
| GC49211 | O-desmethyl Brinzolamide (hydrochloride) | 2967475-56-3 | >98.00% | |
An active metabolite of brinzolamide | ||||
| GC49212 | trans-carboxy Glimepiride | 1217739-04-2 | >95.00% | |
A metabolite of glimepiride | ||||
| GC49213 | trans-hydroxy Glimepiride | 600177-94-4 | >95.00% | |
An active metabolite of glimepiride | ||||
| GC49216 | ADL 08-0011 (hydrochloride) | 170098-43-8 | >90.00% | |
An active metabolite of alvimopan | ||||
| GC49217 | Trifluoperazine N-Glucuronide | 165602-90-4 | >70.00% | |
يتم التعبير عن Trifluoperazine N-Glucuronide (UGT1A4) ، كأحد الأشكال الإسوية UGT1A البشرية ، في الكبد | ||||
| GC49218 | Imidafenacin Metabolite M4 | 503598-17-2 | >90.00% | |
A metabolite of imidafenacin | ||||